Article

Carl Zeiss Meditec AG achieves 10,000th placement of diagnostic device

Carl Zeiss Meditec AG placed its 10,000th diagnostic system (IOLMaster) at a customer site earlier this month. The system calculates all necessary eye measurements for determining the most appropriate replacement implant lens during cataract surgery.

Carl Zeiss Meditec AG placed its 10,000th diagnostic system (IOLMaster) at a customer site earlier this month. The system calculates all necessary eye measurements for determining the most appropriate replacement implant lens during cataract surgery.

Also a completely noninvasive biometry system, the device does not make contact with the patient's eye. The diagnostic system quickly and conveniently measures axial length as well as corneal curvature and anterior chamber depth, according to the company. The alternative for ophthalmologists is ultrasound, a diagnostic procedure that is more time consuming, less accurate, and less comfortable for the patient, the company said.

"We chose to invest in the [diagnostic system] because it is the most accurate method for determining the best lens for our cataract patients," said Douglas Liva, MD, who is in private practice in Paramus, NJ. "The system is more precise, easier to operate, and, ultimately, more comfortable for our patients than immersion ultrasound. For doctors [who] are implanting premium lenses, this technology is essential to the practice in terms of clinical benefits, technician workflow, and patient satisfaction."

In two separate studies conducted by Wolfgang Haigis, PhD, and Warren Hill, MD, more than 95% of all patients with cataracts were measurable. Using state-of-the-art calculation methods, even IOLs for cataract patients who have previously undergone refractive laser correction can be determined easily, according to the company.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.